Patents – biotechnology, chemistry and pharmaceuticals group.

Neil's portfolio has steadily evolved and is now focused on EPO oppositions and appeals, the provision of validity and infringement opinions, due diligence and litigation support, all in the field of pharmaceuticals. He still maintains expertise in advising small pharmaceutical companies in portfolio development and strategy, in particular in conjunction with due diligence for funding and stock market flotations.

Neil has been successful in many oppositions and appeals in the pharmaceutical area – mainly acting for Teva Pharmaceuticals Ltd. on patents concerning the second medical use of approved drugs, formulations, polymorphs and synthetic processes. These cases have often been linked to litigation in EU member states.

Neil is qualified as a patent agent litigator.

Chartered patent attorney 1996; European patent attorney 1996; patent agent litigator; D Young & Co partner 2000.

Neil has 20 years' experience in patents and has spent time in-house at BTG and at Teva Pharmaceutical Industries Ltd in Israel.

Chartered Institute of Patent Attorneys (CIPA); European Patent Institute (epi).

Kings College, University of London (BSc in Pharmacology); Queen Mary College, University of London (Certificate in Intellectual Property Law).